Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude.
Cell-mediated immunity stems from the proliferation of naive T lymphocytes expressing T cell antigen receptors (TCRs) specific for foreign peptides bound to host major histocompatibility complex (MHC) molecules. Because of the tremendous diversity of the T cell repertoire, naive T cells specific for any one peptide:MHC complex (pMHC) are extremely rare. Thus, it is not known how many naive T cells of any given pMHC specificity exist in the body or how that number influences the immune response. By using soluble pMHC class II (pMHCII) tetramers and magnetic bead enrichment, we found that three different pMHCII-specific naive CD4(+) T cell populations vary in frequency from 20 to 200 cells per mouse. Moreover, naive population size predicted the size and TCR diversity of the primary CD4(+) T cell response after immunization with relevant peptide. Thus, variation in naive T cell frequencies can explain why some peptides are stronger immunogens than others.
Moon
James J
JJ
Department of Microbiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Chu
H Hamlet
HH
Pepper
Marion
M
McSorley
Stephen J
SJ
Jameson
Stephen C
SC
Kedl
Ross M
RM
Jenkins
Marc K
MK
D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D000939:Epitopes / Q000276:immunology*; D014644:Genetic Variation; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D007114:Immunization; D051379:Mice; D008817:Mice, Mutant Strains; D010455:Peptides / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000235:genetics
D000939:Epitopes; D000949:Histocompatibility Antigens Class II; D010455:Peptides; D011948:Receptors, Antigen, T-Cell
J Immunol. 2000 Jan 15;164(2):986-93
10623848
J Immunol. 2000 Jun 1;164(11):5782-7
10820256
J Immunol. 2000 Dec 15;165(12):6833-9
11120806
Immunity. 2000 Dec;13(6):771-82
11163193
Annu Rev Immunol. 2001;19:23-45
11244029
Nat Immunol. 2001 May;2(5):415-22
11323695
Nat Immunol. 2001 May;2(5):423-9
11323696
Nat Med. 2001 Aug;7(8):913-9
11479623
J Exp Med. 2002 Mar 4;195(5):657-64
11877489
Immunity. 2002 Mar;16(3):365-77
11911822
Microbes Infect. 2002 Apr;4(5):531-7
11959508
Immunity. 2002 Aug;17(2):191-200
12196290
Annu Rev Immunol. 2006;24:419-66
16551255
Science. 2006 Apr 7;312(5770):114-6
16513943
Immunol Rev. 2006 Jun;211:39-48
16824115
Immunity. 2006 Aug;25(2):261-70
16879996
Immunity. 2006 Oct;25(4):533-43
17046682
J Immunol. 2006 Nov 15;177(10):6705-12
17082583
J Virol. 2007 Feb;81(4):2002-11
17151096
J Exp Med. 2007 Feb 19;204(2):299-309
17261633
Nat Immunol. 2007 Apr;8(4):388-97
17322886
Immunity. 2007 Jun;26(6):827-41
17555991
J Exp Med. 2004 Feb 16;199(4):559-65
14769854
Nat Immunol. 2004 Apr;5(4):418-25
14991052
J Immunol. 2004 Aug 15;173(4):2494-9
15294964
J Exp Med. 1972 Aug 1;136(2):241-60
4114497
J Immunol. 1984 Oct;133(4):2067-74
6332146
Genome. 1989;31(2):652-5
2632348
Nature. 1991 Oct 17;353(6345):660-2
1656278
Cell. 1994 Jan 14;76(1):17-27
8287475
Nature. 1994 May 12;369(6476):151-4
8177320
Science. 1995 Apr 7;268(5207):106-11
7535476
Immunity. 1995 Jun;2(6):655-63
7540944
J Exp Med. 1996 May 1;183(5):2087-95
8642319
Immunity. 1998 Feb;8(2):167-75
9491998
Immunity. 1998 Mar;8(3):353-62
9529152
Immunol Cell Biol. 1998 Feb;76(1):34-40
9553774
Annu Rev Immunol. 1998;16:201-23
9597129
Immunity. 1998 Aug;9(2):169-78
9729037
Protein Sci. 1999 Apr;8(4):921-9
10211839
Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9781-6
10449771
Immunity. 2004 Nov;21(5):669-79
15539153
J Exp Med. 2005 May 16;201(10):1555-65
15897273
Nat Immunol. 2005 Aug;6(8):793-9
16025119
J Immunol. 2006 Mar 1;176(5):3028-36
16493061
J Immunol. 2006 Mar 1;176(5):3037-43
16493062